Experimental data suggest that FGF-23 increase, which targets the remnant nephrons, is an early event in CKD, thereby enhancing renal phosphate excretion and inhibiting the production of 1,25-dihydroxyvitamin D (27). Here, FGF23 is linked to chronic kidney disease.